Pushitai Tablets

This product is used to treat benign prostatic hyperplasia (BPH) and chronic, non-bacterial prostatitis. Its mechanism of action may be related to hindering the conversion of testosterone into dihydrotestosterone in the body and inhibiting the synthesis of leukotrienes and prostaglandins.

The main ingredients of this product: water-soluble pollen extract P5, fat-soluble pollen extract EA10.

This product is a film-coated tablet with small yellowish-brown spots on the surface. After removing the coating, it turns light yellow.

Benign prostatic hyperplasia, chronic, nonbacterial prostatitis.

Oral administration, 1 tablet at a time, 2 times a day, for a course of 3 to 6 months. Or follow the doctor's advice. The best effect can be achieved after 6 months, and it can be continued if necessary. This product can be taken with food or alone. The elderly or those with renal insufficiency do not need to change the dosage.

The vast majority of patients are highly tolerant to this product, and only a very small number of people experience mild abdominal distension, heartburn and nausea, which disappear after stopping the drug.

It is forbidden for children and those who are allergic to this product.

Precautions for children: Children are prohibited from using this product. Precautions for pregnancy and lactation: This experiment has not been conducted and there is no reliable reference. Precautions for the elderly: Elderly patients do not need to change the dosage.

This experiment has not been conducted and there are no reliable references.

Keep away from light, seal tightly, and store in a cool and dry place.

Each tablet contains pollen extract P-570 mg; pollen extract EA-104 mg

24 months.

Nanjing Meirui Pharma Co., Ltd.

• Founded in:

  1996-03-19

• Address:

  No. 50, Xingang Avenue, Nanjing Economic and Technological Development Zone

• Tax NO.:

  9132010060894355X2

• Registered Funds:

  173.452212 million yuan

• Website:

  Log in to view

• Email:

  Log in to view